Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_assertion type Assertion NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_head.
- NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_assertion description "[In addition to increased B-cell lymphoma 2 (Bcl-2) phosphorylation through JNK signaling in response to docetaxel, si-Vav3 enhanced docetaxel-induced apoptosis, as characterized by the accumulation of sub-G1 phase cells and DNA fragmentation, through Bcl-xL/Bcl-2-associated death promoter (Bad) dephosphorylation, resulting in increased caspase-9, caspase-3, and cleaved poly(ADP-ribose) polymerase activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_provenance.
- NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_assertion evidence source_evidence_literature NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_provenance.
- NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_assertion SIO_000772 23566222 NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_provenance.
- NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_assertion wasDerivedFrom befree-2016 NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_provenance.
- NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_assertion wasGeneratedBy ECO_0000203 NP1067363.RA6c0e3Uo1SGIzofNRT7gHDGex452V3f2abOe7-Uq0hoY130_provenance.